1-Ethyl-6-aminouracil
CAS No. 41862-09-3
1-Ethyl-6-aminouracil( 6-AMINO-1-ETHYL-1H-PYRIMIDINE-2,4-DIONE )
Catalog No. M22255 CAS No. 41862-09-3
1-Ethyl-6-aminouracil is an intermediate in the synthesis of a series of new substituted Xanthines which have high affinity and selectivity for the human adenosine A2B receptors.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
Size | Price / USD | Stock | Quantity |
2MG | 45 | In Stock |
|
5MG | 65 | In Stock |
|
10MG | 91 | In Stock |
|
25MG | 165 | In Stock |
|
50MG | 248 | In Stock |
|
100MG | 372 | In Stock |
|
200MG | Get Quote | In Stock |
|
500MG | Get Quote | In Stock |
|
1G | Get Quote | In Stock |
|
Biological Information
-
Product Name1-Ethyl-6-aminouracil
-
NoteResearch use only, not for human use.
-
Brief Description1-Ethyl-6-aminouracil is an intermediate in the synthesis of a series of new substituted Xanthines which have high affinity and selectivity for the human adenosine A2B receptors.
-
Description1-Ethyl-6-aminouracil is an intermediate in the synthesis of a series of new substituted Xanthines which have high affinity and selectivity for the human adenosine A2B receptors.
-
In Vitro——
-
In Vivo——
-
Synonyms6-AMINO-1-ETHYL-1H-PYRIMIDINE-2,4-DIONE
-
PathwayApoptosis
-
TargetAdenosine Receptor
-
RecptorA2B?adenosine receptor
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number41862-09-3
-
Formula Weight155.16
-
Molecular FormulaC6H9N3O2
-
Purity>98% (HPLC)
-
Solubility——
-
SMILESCCn1c(N)cc(=O)nc1=O
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
molnova catalog
related products
-
MSX-3 hydrate
MSX-3 hydrate is a potent, specific adenosine A2A receptor (A2AR) antagonist.
-
N6-[2-(4-Aminophenyl...
A non-selective agonist of Adenosine A3 receptor; has a high affinity for the adenosine A1 and A3 receptors.
-
Piclidenoson
Piclidenoson a selective agonist of adenosine A3 receptor(EC50 values of 0.11 μM) induces robust anti-inflammatory effect in psoriasis patients.